Please provide your email address to receive an email when new articles are posted on . In two phase 3 trials, delgocitinib cream improved hand eczema in a greater proportion of patients vs. vehicle.

AMSTERDAM — The Janus kinase inhibitor delgocitinib may be a better or comparable choice for treating hand eczema than some more established therapies, suggested the results of two separate studies ...

Please provide your email address to receive an email when new articles are posted on . Chronic hand eczema affects nearly one in 10 U.S. adults. Prevalence rates are highest among men, employed ...

Yes, they have a name.

Chronic hand eczema is common, heterogeneous, and frequently occupational, with high rates of sick leave, job disruption, and notable annual per-patient societal costs in the United States. Diagnostic ...

Occupational skin diseases represent a significant and often under‐recognised burden in workplace settings, affecting the health and productivity of millions of workers worldwide. Among these ...

NEW YORK, NY — For immediate control of a hand eczema flare, the old soak and smear approach with moisturizers or corticosteroids might live on, but they are moving to the back of the shelf for ...

The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic hand eczema (CHE). CHE is common condition marked by redness, itching and ...

A deeper understanding of chronic hand eczema (CHE) -- its pathogenesis, clinical subtypes and presentation, and risk factors -- would help expedite quicker diagnosis and appropriate care. That's the ...

Chronic hand eczema (CHE) is a big concern for nurses and other healthcare professionals who wash their hands and use sanitizers. The condition can cause severe discomfort and impact their ability to ...

To calm aggravated skin due to atopic dermatitis and other forms of eczema, follow a personalized regimen every day, not just during flares.

Chronic hand eczema (CHE) is a condition separate from eczema, also known as atopic dermatitis, and has a prevalence rate of approximately 4.7% MADISON, N.J.--(BUSINESS WIRE)--Ninety-five percent (95% ...